Page 136 | Certara

Press Release

Certara Acquires AUTHOR!, a Regulatory and Biostatistics Services Firm in Europe

Broadens European footprint with integrated regulatory services and statistical analysis PRINCETON, NJ.— March 2, 2021–…

CertaraMarch 2, 2021

Blog

The Importance of Continuity of Operations Plans for Gene Therapy Manufacturers

By: James Zoshak The COVID-19 pandemic has added increased risk and uncertainty to gene therapy…

CertaraFebruary 22, 2021

Brochure

Gene Therapy Platform using Certara’s Virtual Twin® Technology

CertaraFebruary 22, 2021

Case Study

Early Value Assessment in Gene Therapy Clinical Trial Design

A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…

CertaraFebruary 12, 2021

Blog

Why Consistency in Patient Safety Narratives is Crucial

“You would not be able to tell 40 different writers were authoring these. It looked…

CertaraFebruary 9, 2021

Publication

BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection

Abstract During a pandemic caused by a novel pathogen (NP), drug repurposing offers the potential…

CertaraFebruary 9, 2021

On-Demand Webinar

RAPS Sponsored Webinar: Efficiency and Technology Pave the Way for the New Age of Narrative Writing

Narratives are an integral part of medical writing. Sponsors sometimes need to prepare large…

CertaraFebruary 8, 2021

White Paper

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

CertaraFebruary 3, 2021

Blog

8 Tips for Successfully Developing Oligonucleotide Therapies

By Eva Gil Berglund and Nathalie H Gosselin Oligonucleotide therapeutics are a validated class of…

CertaraFebruary 1, 2021

Brochure

BaseCase Interactive for Medical Affairs

CertaraJanuary 28, 2021

Certara Acquires AUTHOR!, a Regulatory and Biostatistics Services Firm in Europe

The Importance of Continuity of Operations Plans for Gene Therapy Manufacturers

Gene Therapy Platform using Certara’s Virtual Twin® Technology

Early Value Assessment in Gene Therapy Clinical Trial Design

Why Consistency in Patient Safety Narratives is Crucial

BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection

RAPS Sponsored Webinar: Efficiency and Technology Pave the Way for the New Age of Narrative Writing

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

8 Tips for Successfully Developing Oligonucleotide Therapies

BaseCase Interactive for Medical Affairs

Newsletter sign up

Quick links

Solutions

Contact